Nobody will pick it up because the stock is in a lock down and the VC's pulling the strings in the background have a jack boot on its throat.
I am not speculating on the deal. If you study economic development of nations through technological innovation, take the entire biotech sector as a single corporate, then consider the macro factors of the pharma industry including PDLC's and patent expiries viz the size of the disease target markets, it is obvious a cornerstone deal with a large pharma is required for the benefit of all of Australia...and humanity.
VLA Price at posting:
5.1¢ Sentiment: Buy Disclosure: Held
